117 related articles for article (PubMed ID: 10697501)
1. Potential use of radiolabeled antisense oligonucleotides in oncology.
Gauchez AS; Du Moulinet D'Hardemare A; Lunardi J; Vuillez JP; Fagret D
Anticancer Res; 1999; 19(6B):4989-97. PubMed ID: 10697501
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy using antisense oligodeoxynucleotides labeled with Auger-emitting radionuclides.
Kairemo KJ; Tenhunen M; Jekunen AP
Cancer Gene Ther; 1998; 5(6):408-12. PubMed ID: 9917096
[TBL] [Abstract][Full Text] [Related]
3. Gene inhibition using antisense oligodeoxynucleotides.
Wagner RW
Nature; 1994 Nov; 372(6504):333-5. PubMed ID: 7969490
[TBL] [Abstract][Full Text] [Related]
4. Molecular therapy of human neuroblastoma cells using Auger electrons of 111In-labeled N-myc antisense oligonucleotides.
Watanabe N; Sawai H; Ogihara-Umeda I; Tanada S; Kim EE; Yonekura Y; Sasaki Y
J Nucl Med; 2006 Oct; 47(10):1670-7. PubMed ID: 17015904
[TBL] [Abstract][Full Text] [Related]
5. Antisense therapy in cancer.
Pawlak W; Zolnierek J; Sarosiek T; Szczylik C
Cancer Treat Rev; 2000 Oct; 26(5):333-50. PubMed ID: 11006135
[TBL] [Abstract][Full Text] [Related]
6. Early detection of chemoresistance in vivo through the use of a radiolabeled antisense oligonucleotide.
Touboul M; Gauchez AS; D'Hardemare Adu M; Lunardi J; Deverre JR; Pernin C; Mathieu JP; Vuillez JP; Fagret D
Anticancer Res; 2002; 22(6A):3349-56. PubMed ID: 12530086
[TBL] [Abstract][Full Text] [Related]
7. Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles.
Kodama T; Tan PH; Offiah I; Partridge T; Cook T; George AJ; Blomley MJ
Ultrasound Med Biol; 2005 Dec; 31(12):1683-91. PubMed ID: 16344130
[TBL] [Abstract][Full Text] [Related]
8. [Progress in locked nucleic acid research].
Li SM; Xu X; Liang HP; Li L
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):319-23. PubMed ID: 14992013
[TBL] [Abstract][Full Text] [Related]
9. Antisense imaging: and miles to go before we sleep?
Lewis MR; Jia F
J Cell Biochem; 2003 Oct; 90(3):464-72. PubMed ID: 14523980
[TBL] [Abstract][Full Text] [Related]
10. Antisense oligonucleotide-based therapeutics for cancer.
Dean NM; Bennett CF
Oncogene; 2003 Dec; 22(56):9087-96. PubMed ID: 14663487
[TBL] [Abstract][Full Text] [Related]
11. Antisense and nonantisense effects of antisense Bcl-2 on multiple roles of Bcl-2 as a chemosensitizer in cancer therapy.
Kim R; Emi M; Matsuura K; Tanabe K
Cancer Gene Ther; 2007 Jan; 14(1):1-11. PubMed ID: 17041564
[TBL] [Abstract][Full Text] [Related]
12. Nucleic acid therapeutics for hematologic malignancies--theoretical considerations.
Opalinska JB; Kalota A; Chattopadhyaya J; Damha M; Gewirtz AM
Ann N Y Acad Sci; 2006 Oct; 1082():124-36. PubMed ID: 17145934
[TBL] [Abstract][Full Text] [Related]
13. Protection against myocardial dysfunction induced by global ischemia-reperfusion by antisense-oligodeoxynucleotides directed at beta(1)-adrenoceptor mRNA.
Chen H; Zhang YC; Li D; Phillips MI; Mehta P; Shi M; Mehta JL
J Pharmacol Exp Ther; 2000 Aug; 294(2):722-7. PubMed ID: 10900253
[TBL] [Abstract][Full Text] [Related]
14. The effect of p21 antisense oligodeoxynucleotides on the radiosensitivity of nasopharyngeal carcinoma cells with normal p53 function.
Liu XF; Xia YF; Li MZ; Wang HM; He YX; Zheng ML; Yang HL; Huang WL
Cell Biol Int; 2006 Mar; 30(3):283-7. PubMed ID: 16448826
[TBL] [Abstract][Full Text] [Related]
15. Polyethylenimine-based antisense oligodeoxynucleotides of IL-4 suppress the production of IL-4 in a murine model of airway inflammation.
Seong JH; Lee KM; Kim ST; Jin SE; Kim CK
J Gene Med; 2006 Mar; 8(3):314-23. PubMed ID: 16292779
[TBL] [Abstract][Full Text] [Related]
16. Targeting tumor cell resistance to apoptosis induction with antisense oligonucleotides: progress and therapeutic potential.
Olie RA; Zangemeister-Wittke U
Drug Resist Updat; 2001 Feb; 4(1):9-15. PubMed ID: 11512155
[TBL] [Abstract][Full Text] [Related]
17. Noninvasive imaging of human telomerase reverse transcriptase (hTERT) messenger RNA with 99mTc-radiolabeled antisense probes in malignant tumors.
Liu M; Wang RF; Zhang CL; Yan P; Yu MM; Di LJ; Liu HJ; Guo FQ
J Nucl Med; 2007 Dec; 48(12):2028-36. PubMed ID: 18006621
[TBL] [Abstract][Full Text] [Related]
18. Antisense molecules for targeted cancer therapy.
Wacheck V; Zangemeister-Wittke U
Crit Rev Oncol Hematol; 2006 Jul; 59(1):65-73. PubMed ID: 16750913
[TBL] [Abstract][Full Text] [Related]
19. Modulation of gene expression by antisense and antigene oligodeoxynucleotides and small interfering RNA.
Mahato RI; Cheng K; Guntaka RV
Expert Opin Drug Deliv; 2005 Jan; 2(1):3-28. PubMed ID: 16296732
[TBL] [Abstract][Full Text] [Related]
20. [Antisense oligonucleotides resistance to coxsackievirus B3 infection in HeLa cells].
Sun H; Liu Z; Zhang T
Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):295-7. PubMed ID: 11860805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
